Oral anticoagulant therapy in subjects with congenital or acquired thrombophilia.

Abstract excerpt

Thrombophilia testing is now commonplace. However, testing for heritable thrombophilia does not predict outcome in response to oral anticoagulant therapy. At present there is no conclusive evidence that recurrence on treatment with warfarin with a target International Normalized Ratio of 2.5 is greater in patients with laboratory evidence of heritable thrombophilia compared with those without. Similarly, there is...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Administration, Oral
• Share to Anticoagulants
• Share to Antiphospholipid Syndrome